Carlyle to buy WellDyneRx

Carlyle Group agreed to buy WellDyneRx Inc. Financial terms weren’t announced. Lakeland, Florida-based WelllDyneRx, a pharmacy benefit manager, has a network of retail providers in addition to a mail order and specialty drug pharmacy. WellDyneRx has been expected to sell for $1 billion, according to press reports. J.P. Morgan Securities LLC served as financial advisor and GrayRobinson and Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to WellDyneRx, Inc. Latham & Watkins provided legal advice to Carlyle.

1 August 2016•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles